Abstract
Background: This study determined the prevalence, types, and attitudes towards complementary and alternative medicines (CAMs) and therapies in cancer patients actively undergoing conventional cancer treatment at a regional cancer centre.
Methods: Data were collected using a self-administered questionnaire provided to adult cancer patients attending a comprehensive cancer care centre in regional Australia over a 3-month period.
Results: A participation rate of 89% was recorded over the 3-month period with 285 of 320 cancer patients providing completed data. Mean age was 64 years and slightly more females responded (56%). CAM types used by patients were classified according to US National Centre for Complementary and Alternative Medicine (NCCAM) domains. Overall prevalence of CAM use was 49% (140/285). The NCCAM domains of biologically-based treatments (mainly herbal and vitamin/mineral supplements) and manipulative/body-based methods (chiropractic and massage) were the most popular. Most patients (61%) who used CAM prior to cancer diagnosis continued complementary practices afterwards, and 33% of participants became first-time CAM users only after diagnosis. CAM use appeared to be associated with high patient acceptance and satisfaction which was not related to either cancer diagnosis or prognosis. Patients who used CAM were mainly willing to disclose (77%) this practice to their conventional health care providers.
Conclusions: CAM use is prevalent in regional Australia. Collaborative integration of some CAM practices into conventional cancer care pathways (a process known as integrative oncology) is likely to have substantial patient support.
References
1. WilkinsonJM, SimpsonMD. High use of complementary therapies in a NSW rural community . Aust J Rural Health2001;9:166–71.10.1046/j.1038-5282.2001.00351.xSearch in Google Scholar
2. NaiduS, WilkinsonJM, SimpsonMD. Attitudes of Australian pharmacist towards complementary and alternative medicine . Ann Pharmacother2005;39:1456–61.10.1345/aph.1G089Search in Google Scholar
3. XueCC, ZhangAL, LinV, Da CostaC, StoryDF. Complementary and alternative medicine use in Australia: a national population-based survey . J Altern Complement Med2007;13:643–50.10.1089/acm.2006.6355Search in Google Scholar
4. WilkinsonJM, TinleyP. Knowledge, beliefs, and use of complementary and alternative medicine by Australian podiatric physicians . J Am Podiatr Med Assoc2009;99:121–8.10.7547/0980121Search in Google Scholar
5. DooleyM, BraunLA, PooleS, et al. The integration of complementary medicines in community pharmacy practice. Report on the pharmacy guild of Australia funded project . 2010. Available at: http://guild.org.au/services-programs/research-and-development/archive---fourth-agreement/iig-017Search in Google Scholar
6. National Prescribing Service. NPS Annual Consumer Surveys: Findings about Complementary Medicines Use. 2010. Available at: http://www.nps.org.au/research_and_evaluation/current_ research/complementary_medicines/nps_consumer_survey_cms_use_findingsSearch in Google Scholar
7. EisenbergDM, KesslerRC, FosterC, NorlockFE, CalkinsDR, DelbancoTL. Unconventional medicine use in the United States. Prevalence, costs, and patterns of use . N Engl J Med1993;328:246–52.10.1056/NEJM199301283280406Search in Google Scholar
8. AdamsJ, SibbrittDW, EasthopeG, YoungAF. The profile of women who consult alternative health practitioners in Australia . Med J Aust2003;179:297–300.10.5694/j.1326-5377.2003.tb05551.xSearch in Google Scholar
9. SaydahSH, EberhardtMS. Use of complementary andalternative medicines among adults with chronic disease: United States 2002 . J Altern Complement Med2006;12:805–12.10.1089/acm.2006.12.805Search in Google Scholar
10. ErnstE, CassilethBR. The prevalence of complementary/alternative medicine in cancer . Cancer1998;83:777–82.10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-OSearch in Google Scholar
11. CornerJ, YardleyJ, MaherEJ, et al. Patterns ofcomplementary and alternative medicine use among patients undergoing cancer treatment . Eur J Cancer Care (Engl)2009;18:271–9.10.1111/j.1365-2354.2007.00911.xSearch in Google Scholar
12. DengGE, FrenkelM, CohenL, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals . J Soc Integr Oncol2009;7:85–120.Search in Google Scholar
13. DengG, CassilethBR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance . CA Cancer J Clin2005;55:109–16.10.3322/canjclin.55.2.109Search in Google Scholar
14. CohenAJ, MenterAJ, HaleL. Acupuncture: role incomprehensive cancer care – a primer . Integr Cancer Ther2005;4:131–43.10.1177/1534735405276419Search in Google Scholar PubMed
15. Cancer Institute NSW. NSW cancer plan 2007–2010 . Available at: http://www.cancerinstitute.com.au/cancer_inst/publications/pdfs/NSWCancerPlan2007-2010.pdfSearch in Google Scholar
16. National Center for Complementary and Alternative Medicine (NCCAM). What is CAM? 2007. Available at: http://nccam.nih.gov/health/whatiscam/Search in Google Scholar
17. BegbieSD, KerestesZL, BellDR. Patterns of alternativemedicine use by cancer patients . Med J Aust1996;165:545–8.10.5694/j.1326-5377.1996.tb138639.xSearch in Google Scholar PubMed
18. LieD, BrokerJ. Development and validation of the CAM health belief questionnaire (CHBQ) and CAM use and attitudes amongst medical students . BMC Med Educ2004;4:1–9.10.1186/1472-6920-4-2Search in Google Scholar PubMed PubMed Central
19. WilkinsonJM, JelinekH. Complementary medicine use among attendees at a rural health screening clinic . Complement Ther Clin Pract2009;15:80–4.10.1016/j.ctcp.2008.12.005Search in Google Scholar PubMed
20. BroomA, AdamsJ. Oncology clinicians’ accounts of discussing complementary and alternative medicine with their patients . Health2009;13:317–36.10.1177/1363459308101806Search in Google Scholar PubMed
21. BlythFM, MarchLM, NicholasMK, CousinsM. Self-management of chronic pain: a population-based study . Pain2005;113:285–92.10.1016/j.pain.2004.12.004Search in Google Scholar PubMed
22. HaetzmanM, ElliotAM, SmithBH, HannafordP, ChambersWA. Chronic pain and the use of conventional and alternative therapy . Fam Pract2003;20:147–54.10.1093/fampra/20.2.147Search in Google Scholar PubMed
©2014 by Walter de Gruyter Berlin / Boston
Articles in the same Issue
- Frontmatter
- Review
- A review on Ipomoea carnea: pharmacology, toxicology and phytochemistry
- Preclinical Studies
- Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats
- Pharmacognostical standardization and antidiabetic activity of Syzygium cumini (Linn.) barks (Myrtaceae) on streptozotocin-induced diabetic rats
- Preventive effects of the methanol soluble fraction of Millettia macrophylla Benth (Fabaceae) on an osteoporosis-like model of ovariectomized Wistar rats
- Detoxification of Echis ocellatus venom-induced toxicity by Annona senegalensis Pers
- Subacute antidiabetic and in vivo antioxidant effects of methanolic extract of Bridelia micrantha (Hochst Baill) leaf on alloxan-induced hyperglycaemic rats
- Effect of Persea americana (avocado) fruit extract on the level of expression of adiponectin and PPAR-γ in rats subjected to experimental hyperlipidemia and obesity
- In vitro protective effects of Scutellaria litwinowii root extract against H2O2-induced DNA damage and cytotoxicity
- Clinical Studies
- The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial
- Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre
- Education Forum
- Implementing blended learning into the academic programs of Rajiv Gandhi University of Health Sciences, Karnataka
Articles in the same Issue
- Frontmatter
- Review
- A review on Ipomoea carnea: pharmacology, toxicology and phytochemistry
- Preclinical Studies
- Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats
- Pharmacognostical standardization and antidiabetic activity of Syzygium cumini (Linn.) barks (Myrtaceae) on streptozotocin-induced diabetic rats
- Preventive effects of the methanol soluble fraction of Millettia macrophylla Benth (Fabaceae) on an osteoporosis-like model of ovariectomized Wistar rats
- Detoxification of Echis ocellatus venom-induced toxicity by Annona senegalensis Pers
- Subacute antidiabetic and in vivo antioxidant effects of methanolic extract of Bridelia micrantha (Hochst Baill) leaf on alloxan-induced hyperglycaemic rats
- Effect of Persea americana (avocado) fruit extract on the level of expression of adiponectin and PPAR-γ in rats subjected to experimental hyperlipidemia and obesity
- In vitro protective effects of Scutellaria litwinowii root extract against H2O2-induced DNA damage and cytotoxicity
- Clinical Studies
- The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial
- Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre
- Education Forum
- Implementing blended learning into the academic programs of Rajiv Gandhi University of Health Sciences, Karnataka